Geode Capital Management’s Bioventus BVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.7M Buy
1,168,247
+48,009
+4% +$403K ﹤0.01% 2342
2025
Q4
$8.34M Buy
1,120,238
+19,388
+2% +$139K ﹤0.01% 2494
2025
Q3
$7.37M Buy
1,100,850
+45,947
+4% +$319K ﹤0.01% 2582
2025
Q2
$6.98M Buy
1,054,903
+122,137
+13% +$866K ﹤0.01% 2558
2025
Q1
$8.54M Sell
932,766
-7,110
-0.8% -$71K ﹤0.01% 2389
2024
Q4
$9.87M Sell
939,876
-620
-0.1% -$7.33K ﹤0.01% 2382
2024
Q3
$11.2M Buy
940,496
+65,374
+7% +$565K ﹤0.01% 2309
2024
Q2
$5.03M Buy
875,122
+450,358
+106% +$2.47M ﹤0.01% 2715
2024
Q1
$2.21M Buy
424,764
+17,320
+4% +$84.6K ﹤0.01% 3077
2023
Q4
$2.15M Buy
407,444
+22,742
+6% +$90K ﹤0.01% 3074
2023
Q3
$1.27M Buy
384,702
+43,526
+13% +$153K ﹤0.01% 3230
2023
Q2
$986K Sell
341,176
-295,927
-46% -$568K ﹤0.01% 3365
2023
Q1
$682K Buy
637,103
+14,456
+2% +$27.7K ﹤0.01% 3527
2022
Q4
$1.63M Buy
622,647
+30,249
+5% +$132K ﹤0.01% 3139
2022
Q3
$4.15M Buy
592,398
+103,659
+21% +$812K ﹤0.01% 2766
2022
Q2
$3.33M Buy
488,739
+39,359
+9% +$402K ﹤0.01% 2928
2022
Q1
$6.34M Buy
449,380
+30,292
+7% +$405K ﹤0.01% 2653
2021
Q4
$6.07M Buy
419,088
+197,760
+89% +$2.81M ﹤0.01% 2782
2021
Q3
$3.13M Buy
221,328
+61,155
+38% +$941K ﹤0.01% 3167
2021
Q2
$2.82M Buy
160,173
+25,172
+19% +$406K ﹤0.01% 3166
2021
Q1
$2.06M Buy
+135,001
New +$1.92M ﹤0.01% 3240

Other funds holding BVS